These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19660707)

  • 1. Platelet reactivity and stent thrombosis: still some issues to solve.
    Perez de Prado A; Cuellas C; Diego A; de Miguel A; Fernandez-Vazquez F
    J Am Coll Cardiol; 2009 Aug; 54(7):666-7; author reply 667-8. PubMed ID: 19660707
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
    Sibbing D; Braun S; Morath T; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
    J Am Coll Cardiol; 2009 Mar; 53(10):849-56. PubMed ID: 19264241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care platelet function analysis ready for prime time?
    Mahla E; Antonino MJ; Tantry US; Gurbel PA
    J Am Coll Cardiol; 2009 Mar; 53(10):857-9. PubMed ID: 19264242
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
    Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
    Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
    Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting thrombotic events: creating a complex approach for a complex condition.
    Shantsila E; Lip GY
    Thromb Haemost; 2008 Dec; 100(6):962-4. PubMed ID: 19132217
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis.
    Aradi D; Komócsi A; Vorobcsuk A; Rideg O; Tokés-Füzesi M; Magyarlaki T; Horváth IG; Serebruany VL
    Am Heart J; 2010 Sep; 160(3):543-51. PubMed ID: 20826265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of dual antiplatelet therapy.
    Murray AT; Sederberg JH
    Semin Cardiothorac Vasc Anesth; 2011; 15(1-2):40-3. PubMed ID: 21840879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subacute stent thrombosis owing to complete clopidogrel resistance successfully managed with prasugrel.
    Flaherty MP; Johnston PV; Rade JJ
    J Invasive Cardiol; 2011 Jul; 23(7):300-4. PubMed ID: 21725128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting versus bare-metal stents: when and for whom?
    Beyar R; Nikolsky E
    J Invasive Cardiol; 2008 Mar; 20(3):105-6. PubMed ID: 18316824
    [No Abstract]   [Full Text] [Related]  

  • 11. Triple antiplatelet therapy for clopidogrel resistance with stent malapposition: a case report.
    Ding FH; Zhang Q; Zhang RY; Hu J; Shen J; Zhao LP; DU R; Zhang X; Shen WF
    Chin Med J (Engl); 2009 Sep; 122(18):2186-8. PubMed ID: 19781309
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to antiplatelet resistance is it justified?
    Steinhubl SR; Charnigo R; Moliterno DJ
    J Am Coll Cardiol; 2005 Jun; 45(11):1757-8. PubMed ID: 15936601
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the degree of platelet aggregation inhibition with prasugrel versus clopidogrel and clinical outcomes in patients with unprotected left main disease treated with everolimus-eluting stents.
    Migliorini A; Valenti R; Parodi G; Marcucci R; Abbate R; Carrabba N; Gensini GF; Antoniucci D
    Am J Cardiol; 2013 Dec; 112(12):1843-8. PubMed ID: 24063827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.
    Trenk D; Hochholzer W; Fromm MF; Chialda LE; Pahl A; Valina CM; Stratz C; Schmiebusch P; Bestehorn HP; Büttner HJ; Neumann FJ
    J Am Coll Cardiol; 2008 May; 51(20):1925-34. PubMed ID: 18482659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions.
    Geisler T; Zürn C; Simonenko R; Rapin M; Kraibooj H; Kilias A; Bigalke B; Stellos K; Schwab M; May AE; Herdeg C; Gawaz M
    Eur Heart J; 2010 Jan; 31(1):59-66. PubMed ID: 19812059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.
    Stone GW; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri E; Gurbel PA; Xu K; Parise H; Kirtane AJ; Brodie BR; Mehran R; Stuckey TD;
    Lancet; 2013 Aug; 382(9892):614-23. PubMed ID: 23890998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stents and antiplatelet therapy.
    Fassa AA; Urban P
    Adv Cardiol; 2012; 47():114-24. PubMed ID: 22906907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.
    Buonamici P; Marcucci R; Migliorini A; Gensini GF; Santini A; Paniccia R; Moschi G; Gori AM; Abbate R; Antoniucci D
    J Am Coll Cardiol; 2007 Jun; 49(24):2312-7. PubMed ID: 17572245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time dependence of clopidogrel loading effect: platelet activation versus platelet aggregation.
    Gurbel PA; Bliden KP; Antonino MJ; Gesheff T; Cummings CC; Dubois BV; Herzog WR; Tantry US
    Thromb Res; 2012 Jan; 129(1):1-2. PubMed ID: 21862113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.